.Pharmacolibrary.Drugs.R_RespiratorySystem.R03A_AdrenergicsInhalants.R03AC05_Rimiterol.Rimiterol .Pharmacolibrary.Drugs.R_RespiratorySystem.R03A_AdrenergicsInhalants.R03AC05_Rimiterol.Rimiterol| name: | Rimiterol |
| ATC code: | R03AC05 | route: | inhalation |
| n-compartments | 1 |
Rimiterol is a short-acting beta-2 adrenergic receptor agonist previously used as a bronchodilator in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is not widely used or approved in current clinical practice, having largely been replaced by other beta-2 agonists such as salbutamol.
Pharmacokinetic parameters were not identified in published literature for any population. Reported values are plausible estimates based on similarity to other short-acting beta-2 agonists orally inhaled, such as salbutamol, and available secondary sources.